Factitious Hypoglycemia: Diagnosis by Measurement of Serum C-Peptide Immunoreactivity and Insulin-Binding Antibodies
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In seven patients with factitious hypoglycemia due to the surreptitious injection of insulin, we made the diagnosis by measurements of plasma insulin and C-peptide immunoreactivity (in seven patients), facilitated by the finding of circulating insulin-binding antibodies (in two patients). The simultaneous demonstration of low plasma glucose, high immunoreactive insulin and suppressed C-peptide immunoreactivity represents a triad of results pathognomonic of exogenous insulin administration. Determination of plasma free C-peptide and free insulin permitted patients with high titers of insulin antibodies, including those with a history of insulin-treated diabetes, to be studied and diagnosed in a way similar to that in subjects who had no circulating insulin antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sulfonylurea-Induced Factitious Hypoglycemia: A Growing Problem
Jordan, R. M. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630150084023 · Cited by 47
Research works printed but not linked: 41
- Sonenthal, 1944, Ill Med J, 85, 17
- 10.7326/0003-4819-24-3-487 · DOI
- Rynearson, 1947, Med Clin North Am, 31, 477, 10.1016/S0025-7125(16)35848-5 · doi:10.1016/s0025-7125(16)35848-5
- 10.1210/jcem-13-5-587 · DOI
- 10.7326/0003-4819-48-6-1328 · doi:10.7326/0003-4819-48-6-1328
- Hoffman, 1961, Surg Clin North Am, 41, 951, 10.1016/S0039-6109(16)36437-4 · doi:10.1016/s0039-6109(16)36437-4
- Ibbertson, 1961, NZ Med J, 60, 534
- 10.1016/0026-0495(68)90159-5 · DOI
- 10.1136/bmj.2.5601.346 · DOI
- Palumbo, 1969, Mayo Clin Proc, 44, 725
- 10.1016/0002-9343(71)90292-0 · DOI
- 10.1136/bmj.4.5843.792-e · DOI
- 10.7326/0003-4819-82-2-201 · DOI
- Beischer, 1975, Verh Dtsch Ges Inn Med, 81, 1493
- Service, 1975, Mayo Clin Proc, 50, 697
- 10.1055/s-0028-1111123 · DOI
- 10.1001/jama.1961.63040100019020 · DOI
- 10.1097/00007611-197106000-00014 · doi:10.1097/00007611-197106000-00014
- 10.1136/bmj.1.5792.87 · doi:10.1136/bmj.1.5792.87
- 10.1001/jama.1974.03230430016014 · doi:10.1001/jama.1974.03230430016014
- Walfish, 1975, Can Med Assoc J, 112, 71
- 10.1001/archinte.134.2.336 · DOI
- 10.1210/jcem-35-2-271 · DOI
- Rubenstein AH, Mako ME, Starr JI, et al: Circulating proinsulin in patients with islet cell tumors, Diabetes. Proceedings of the Eighth Congress of the International Diabetes Federation, Brussels, July 15–20, 1973. Edited by WJ Malaisse. J Pirart, Vallance-Owen J. Amsterdam, Exerpta Medica, 1974, pp 736–752
- Service, 1976, Mayo Clin Proc, 51, 417
- 10.7326/0003-4819-79-2-239 · DOI · Paper page
- 10.1620/tjem.107.277 · DOI
- 10.1056/NEJM197305312882202 · DOI
- 10.2337/diabetes.26.1.22 · DOI
- 10.1016/0006-291X(70)90813-2 · DOI
- Gavin, 1973, J Biol Chem, 248, 2202, 10.1016/S0021-9258(19)44205-1 · DOI · Paper page
- 10.1172/JCI108360 · DOI · Paper page
- 10.1016/S0140-6736(62)90231-3 · DOI
- 10.1111/j.1749-6632.1974.tb14443.x · DOI
- 10.1056/NEJM195805082581903 · DOI
- Block, 1972, Diabetes, 21, 1013, 10.2337/diab.21.10.1013 · DOI
- 10.1055/s-0028-1093819 · doi:10.1055/s-0028-1093819
- Nakagawa, 1973, Diabetes, 22, 590, 10.2337/diab.22.8.590 · DOI · Paper page
- Steiner, 1968, Diabetes, 17, 725, 10.2337/diab.17.12.725 · DOI · Paper page
- 10.1055/s-0028-1093990 · doi:10.1055/s-0028-1093990
- 10.2190/2W0Q-HFJT-233Q-95JR · DOI
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Polonsky, K. S., Licinio-Paixao, J., Given, B. D., Pugh, W., Rue, P., Galloway, J., Karrison, T., & Frank, B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112308 · Cited by 359
Clinical Features of 52 Neonates with Hyperinsulinism
de Lonlay-Debeney, P., Poggi-Travert, F., Fournet, J.-C., Sempoux, C., Vici, C. D., Brunelle, F., Touati, G., Rahier, J., Junien, C., Nihoul-Fékété, C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401505 · Cited by 294
Metadata
- Authors
- Scarlett, J. A., Mako, M. E., Rubenstein, A. H., Blix, P. M., Goldman, J., Horwitz, D. L., Tager, H., Jaspan, J. B., Stjernholm, M. R., & Olefsky, J. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1977-11-10
- Volume
- 297
- Issue
- 19
- Pages
- 1029-1032
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2068699094
- Cited by
- 142
- References
- 1
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factitious Hypoglycemia: Diagnosis by Measurement of Serum C-Peptide Immunoreactivity and Insulin-Binding Antibodies. https://app.cochat.ai/papers/10.1056/nejm197711102971903
- The paper
- Scarlett, J. A., Mako, M. E., Rubenstein, A. H., Blix, P. M., Goldman, J., Horwitz, D. L., Tager, H., Jaspan, J. B., Stjernholm, M. R., & Olefsky, J. M. (1977). Factitious Hypoglycemia: Diagnosis by Measurement of Serum C-Peptide Immunoreactivity and Insulin-Binding Antibodies. New England Journal of Medicine. https://doi.org/10.1056/nejm197711102971903
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.